Furthermore, these DEGs exhibited enrichment in pathways associated with p53 signaling, cell cycle, and DNA replication, which could potentially promote tumor progression in the high-risk cohort (Supplementary Fig. S1C). This evidence concerns the gene TP53 and neoplasm.